<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31450553</article-id>
<article-id pub-id-type="pmc">6747530</article-id>
<article-id pub-id-type="doi">10.3390/ijms20174127</article-id>
<article-id pub-id-type="publisher-id">ijms-20-04127</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cortical Seizures in <italic>FoxG1<sup>+/−</sup></italic> Mice are Accompanied by Akt/S6 Overactivation, Excitation/Inhibition Imbalance and Impaired Synaptic Transmission</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Testa</surname>
<given-names>Giovanna</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-04127">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olimpico</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-20-04127">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pancrazi</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-20-04127">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9812-579X</contrib-id>
<name>
<surname>Borello</surname>
<given-names>Ugo</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-20-04127">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cattaneo</surname>
<given-names>Antonino</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-04127">1</xref>
<xref ref-type="aff" rid="af4-ijms-20-04127">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4333-6378</contrib-id>
<name>
<surname>Caleo</surname>
<given-names>Matteo</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-20-04127">2</xref>
<xref ref-type="aff" rid="af5-ijms-20-04127">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Costa</surname>
<given-names>Mario</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-20-04127">2</xref>
<xref ref-type="corresp" rid="c1-ijms-20-04127">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mainardi</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-04127">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-04127">2</xref>
<xref ref-type="corresp" rid="c1-ijms-20-04127">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-04127"><label>1</label>Laboratory of Biology “Bio@SNS”, Scuola Normale Superiore, 56126 Pisa, Italy</aff>
<aff id="af2-ijms-20-04127"><label>2</label>Institute of Neuroscience, Italian National Research Council (IN-CNR), 56124 Pisa, Italy</aff>
<aff id="af3-ijms-20-04127"><label>3</label>Unit of Cell and Developmental Biology, Department of Biology, University of Pisa, 56123 Pisa, Italy</aff>
<aff id="af4-ijms-20-04127"><label>4</label>European Brain Research Institute “Rita Levi-Montalcini” (EBRI), 00161 Rome, Italy</aff>
<aff id="af5-ijms-20-04127"><label>5</label>Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy</aff>
<author-notes>
<corresp id="c1-ijms-20-04127"><label>*</label>Correspondence: <email>Mario.costa@in.cnr.it</email> (M.C.); <email>marco.mainardi@sns.it</email> (M.M.)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>17</issue>
<elocation-id>4127</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The correct morphofunctional shaping of the cerebral cortex requires a continuous interaction between intrinsic (genes/molecules expressed within the tissue) and extrinsic (e.g., neural activity) factors at all developmental stages. Forkhead Box G1 (FOXG1) is an evolutionarily conserved transcription factor, essential for the cerebral cortex patterning and layering. FOXG1-related disorders, including the congenital form of Rett syndrome, can be caused by deletions, intragenic mutations or duplications. These genetic alterations are associated with a complex phenotypic spectrum, spanning from intellectual disability, microcephaly, to autistic features, and epilepsy. We investigated the functional correlates of dysregulated gene expression by performing electrophysiological assays on <italic>FoxG1<sup>+/−</sup></italic> mice. Local Field Potential (LFP) recordings on freely moving animals detected cortical hyperexcitability. On the other hand, patch-clamp recordings showed a downregulation of spontaneous glutamatergic transmission. These findings were accompanied by overactivation of Akt/S6 signaling. Furthermore, the expression of vesicular glutamate transporter 2 (vGluT2) was increased, whereas the level of the potassium/chloride cotransporter KCC2 was reduced, thus indicating a higher excitation/inhibition ratio. Our findings provide evidence that altered expression of a key gene for cortical development can result in specific alterations in neural circuit function at the macro- and micro-scale, along with dysregulated intracellular signaling and expression of proteins controlling circuit excitability.</p>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>Rett syndrome</kwd>
<kwd>electrophysiology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-04127" sec-type="intro">
<title>1. Introduction</title>
<p>The complexity of the mature six-layered structure of the mammalian cerebral cortex is achieved through a long and precisely regulated developmental process controlling neurogenesis, neuronal migration and differentiation. Cortical abnormalities caused by altered expression of genes regulating brain development at different levels, e.g., gene transcription [<xref ref-type="bibr" rid="B1-ijms-20-04127">1</xref>] or cell migration [<xref ref-type="bibr" rid="B2-ijms-20-04127">2</xref>], constitute a significant fraction of pediatric pathologies associated to intellectual disability [<xref ref-type="bibr" rid="B3-ijms-20-04127">3</xref>]. Among these, homozygous mutations in <italic>FoxG1</italic> lead to perinatal lethality in mice [<xref ref-type="bibr" rid="B4-ijms-20-04127">4</xref>], in line with the role of this transcription factor in orchestrating telencephalic development [<xref ref-type="bibr" rid="B5-ijms-20-04127">5</xref>]. On the other hand, heterozygous mutations in <italic>FOXG1</italic> are compatible with life, but result in reduced size of cerebral hemispheres, alterations in cortical layering [<xref ref-type="bibr" rid="B6-ijms-20-04127">6</xref>] and severe intellectual disability with autism spectrum disorder (ASD)-like features [<xref ref-type="bibr" rid="B7-ijms-20-04127">7</xref>]. From a clinical point of view, the phenotype associated with mutations in <italic>FOXG1</italic> constitutes a significant fraction of Rett syndrome (RTT) cases (OMIM 613454) [<xref ref-type="bibr" rid="B8-ijms-20-04127">8</xref>]. In comparison to “classical” RTT due to <italic>MECP2</italic> mutations, <italic>FoxG1</italic>-associated variants share ASD signs, but also tend to show an earlier onset, a higher occurrence of epileptic seizures, and callosal abnormalities [<xref ref-type="bibr" rid="B9-ijms-20-04127">9</xref>]. In addition, the localization of <italic>FoxG1</italic> on the 14q12 chromosomal region allows the mutation to cause the pathology in both sexes, in contrast to X-linked RTT caused by <italic>MECP2</italic> mutations [<xref ref-type="bibr" rid="B7-ijms-20-04127">7</xref>].</p>
<p><italic>FOXG1</italic>-associated RTT is mostly due to deletions [<xref ref-type="bibr" rid="B7-ijms-20-04127">7</xref>]; consistently, the cardinal signs of this neurodevelopmental pathology are reproduced in <italic>FoxG1<sup>+/−</sup></italic> mice harboring a disrupted allele of the gene, including reduced cortical volume and cognitive impairment [<xref ref-type="bibr" rid="B4-ijms-20-04127">4</xref>,<xref ref-type="bibr" rid="B10-ijms-20-04127">10</xref>].</p>
<p>Among the abnormalities contributing to the RTT phenotype, epilepsy gives a significant negative contribution to the patients’ quality of life. Thus, a better understanding of the details of this comorbidity, from both functional and biochemical-molecular points of view, could be exploited to instruct the elaboration of more effective therapies. In this regard, we recently showed that <italic>FoxG1<sup>+/−</sup></italic> mice display hippocampal epileptiform electrophysiological events and higher propensity to proconvulsant-induced generalized seizures, in comparison to wild type controls [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>]. However, the cortical in vivo electrophysiological phenotype of <italic>FoxG1<sup>+/−</sup></italic> mice has only been studied incompletely. Indeed, visual evoked potential recordings under anesthesia demonstrated reduced visual acuity, despite a normal retinal structure, which can be related to the deficit in face recognition and mismatch between looking and reaching observed in juvenile <italic>FOXG1</italic>-haploinsufficient patients [<xref ref-type="bibr" rid="B12-ijms-20-04127">12</xref>]. These findings prompted us to better study cortical electrophysiology in freely moving <italic>FoxG1<sup>+/−</sup></italic> mice and, using local field potential recordings with chronically implanted electrodes, we detected a dramatic increase in epileptiform activity with respect to wild type controls. In search for a biochemical correlate of these data, we found an abnormally high phosphorylation of Akt and ribosomal protein S6, two key controllers of neuronal circuit development and plasticity [<xref ref-type="bibr" rid="B13-ijms-20-04127">13</xref>], which was accompanied by higher expression of vesicular glutamate transporter 2 (vGluT2). In addition, we mined the FoxG1 ChIP-Seq dataset of cortical neurons [<xref ref-type="bibr" rid="B6-ijms-20-04127">6</xref>] to identify pathways directly regulated by FoxG1 and to validate our findings. Finally, patch-clamp recordings of synaptic activity showed an impairment in spontaneous excitatory transmission.</p>
<p>Our results show that the cortex of <italic>FoxG1<sup>+/−</sup></italic> mice is affected by opposite network-wide and micro-circuit alterations, leading to higher excitability and depressed synaptic transmission, respectively. These functional alterations are paralleled by hyperactivation of signal transduction pathways linking neural activity to protein synthesis, which can contribute to excitatory/inhibitory imbalance in <italic>FoxG1</italic> mutant mice.</p>
</sec>
<sec id="sec2-ijms-20-04127" sec-type="results">
<title>2. Results</title>
<sec id="sec2dot1-ijms-20-04127">
<title>2.1. Epileptiform Electrographic Activity in FoxG1<sup>+/−</sup> Mice</title>
<p>Based on our previous findings showing higher propensity to proconvulsant-induced generalized seizures [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>]), we assessed the electrophysiological profile of the primary motor cortex (M1) of freely moving <italic>FoxG1<sup>+/−</sup></italic> mice, using chronic implants for local field potential (LFP) recordings (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>A). Quantitative analysis of the data revealed an overall increase in the frequency of high-amplitude spikes in <italic>FoxG1<sup>+/−</sup></italic> animals (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>B), in comparison to controls. Spiking events were then sorted according to their clustering (i.e., single vs grouped events) and duration (see Materials and Methods). A similar, significant trend could be observed for isolated spikes, interictal events, and electrographic seizures (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>C–E), which were dramatically increased in comparison to wild type animals. In addition, it is important to note that isolated and interictal events were increased about 4.5- and 3-fold, whereas seizure events were 140-fold more frequent, in <italic>FoxG1<sup>+/−</sup></italic> mice than in controls. Thus, the global increase in cortical excitability (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>B) tends to boost the occurrence of long-lasting high-amplitude spiking events (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>E), in comparison to single or short-lasting events (<xref ref-type="fig" rid="ijms-20-04127-f001">Figure 1</xref>C,D).</p>
</sec>
<sec id="sec2dot2-ijms-20-04127">
<title>2.2. Hyperactivation of Signal Transduction and Excitation/Inhibition Imbalance in FoxG1<sup>+/−</sup> Mice</title>
<p>The findings from the LFP recordings prompted us to look for a biochemical correlate, which could account for the higher M1 excitability. First, we analyzed Akt activation, and detected a significant increase in phospho-Thr<sup>308</sup>-Akt (<xref ref-type="fig" rid="ijms-20-04127-f002">Figure 2</xref>A). Then, we moved downstream, following this signaling pathway, and quantified the level of phospho-Ser<sup>235-236</sup>S6. Consistent with Akt hyperactivation, phosphorylation of S6 was significantly higher in <italic>FoxG1<sup>+/−</sup></italic> mice than in controls (<xref ref-type="fig" rid="ijms-20-04127-f002">Figure 2</xref>B).</p>
<p>These alterations in intracellular signaling can affect the expression of proteins controlling synaptic transmission. Therefore, we measured the levels of synaptic neurotransmitter transporters. On the one hand, expression of vesicular GABA transporter (vGAT) and vesicular glutamate transporter 1 (vGluT1) did not significantly change in <italic>FoxG1<sup>+/−</sup></italic> mice (<italic>FoxG1<sup>+/−</sup></italic> 95.2 ± 7.6%, WT 100.0 ± 5.8%, Student’s <italic>t</italic>-test, <italic>p</italic> = 0.629, <italic>n</italic> = 5 for both groups). On the other hand, expression of vesicular glutamate transporter 2 (vGluT2) was significantly higher in the M1 of <italic>FoxG1<sup>+/−</sup></italic> mice compared to wild type animals (<xref ref-type="fig" rid="ijms-20-04127-f002">Figure 2</xref>C). We also quantified the expression of the potassium-chloride cotransporter, KCC2, and, consistent with our previous data on hippocampal samples [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>], we found a significant decrease in its level in the M1 of <italic>FoxG1<sup>+/−</sup></italic> mice (<xref ref-type="fig" rid="ijms-20-04127-f002">Figure 2</xref>D). Taken together, the above described data indicate a disruption in intracellular signaling, correlated with changes in the expression of proteins contributing to the regulation of the cortical excitation/inhibition balance.</p>
</sec>
<sec id="sec2dot3-ijms-20-04127">
<title>2.3. FoxG1 Directly Regulates Akt Pathway Gene Network</title>
<p>Our data demonstrate that reduced expression of <italic>FoxG1</italic> causes Akt hyperactivation in the mouse cortex. To determine at which level in the Akt pathway regulation FoxG1 plays a role, we analyzed its target genes, by taking advantage of the ChIP-Seq database published in [<xref ref-type="bibr" rid="B6-ijms-20-04127">6</xref>]. This database was obtained from E15.5 mouse cortex samples i.e., when FoxG1 starts to be expressed in differentiated neurons. We classified these genes into groups of known cellular and biochemical pathways (see complete list in <xref ref-type="app" rid="app1-ijms-20-04127">Supplementary Table S1</xref>), and found that most of the genes playing a role in the Akt pathway are FoxG1 target genes (<xref ref-type="fig" rid="ijms-20-04127-f003">Figure 3</xref>). This demonstrates a general role of FoxG1 in Akt pathway regulation and suggests that this pathway may mediate the effects of FoxG1 on cortical neuronal activity.</p>
</sec>
<sec id="sec2dot4-ijms-20-04127">
<title>2.4. Impaired Spontaneous Excitatory Synaptic Transmission in FoxG1<sup>+/−</sup> Mice</title>
<p>Taking into account the data indicating cortical macrocircuit hyperexcitability, along with altered expression of vGluT2 and KCC2, we investigated spontaneous synaptic transmission in the primary motor cortex of <italic>FoxG1<sup>+/−</sup></italic> mice, by measuring miniature excitatory postsynaptic currents (mEPSCs) with patch-clamp recordings. Strikingly, we found that both mEPSC frequency and amplitude were decreased in <italic>FoxG1<sup>+/−</sup></italic> mice, compared to wild type controls (<xref ref-type="fig" rid="ijms-20-04127-f004">Figure 4</xref>A–C).</p>
<p>These data indicate that, at the single-neuron level, cortical spontaneous excitatory synaptic transmission is downregulated in <italic>FoxG1<sup>+/−</sup></italic> mice.</p>
</sec>
</sec>
<sec id="sec3-ijms-20-04127" sec-type="discussion">
<title>3. Discussion</title>
<p>Mutations in <italic>FoxG1</italic> have been recently recognized as causing non-X-linked Rett syndrome [<xref ref-type="bibr" rid="B7-ijms-20-04127">7</xref>,<xref ref-type="bibr" rid="B14-ijms-20-04127">14</xref>]. Basic neurophysiology studies on animal models can help in better understanding the consequences of this genetic alteration, and contribute to the quest for an effective therapy. In line with this, we analyzed cortical pathophysiology of <italic>FoxG1<sup>+/−</sup></italic> haploinsufficient mice employing EEG recordings in freely moving animals. We show, in the primary motor cortex, the occurrence of spontaneous epileptiform events, which cluster into electrographic seizures with very high frequency. These results agree with our previous findings in the hippocampus of <italic>FoxG1<sup>+/−</sup></italic> mice [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>] and, altogether, they indicate an enhanced propensity to epilepsy in brain structures essential to movement and cognition.</p>
<p>Since epileptiform activity can trigger modifications in gene/protein expression [<xref ref-type="bibr" rid="B15-ijms-20-04127">15</xref>] which, in turn, can increase seizure frequency and severity, we analyzed the phosphorylation of S6 ribosomal protein, which is acutely increased in rats following pentylenetetrazole (PTZ)-induced seizures [<xref ref-type="bibr" rid="B16-ijms-20-04127">16</xref>]. The expression of phospho-S6 was higher in the cortex of <italic>FoxG1<sup>+/−</sup></italic> mice, which indicates chronically elevated levels (no particular stimuli or treatments were delivered to the animals before sacrifice). This is in agreement with human data showing higher phospho-S6 in the cortex resected from patients affected by drug-resistant temporal lobe epilepsy [<xref ref-type="bibr" rid="B17-ijms-20-04127">17</xref>]. Moreover, S6 phosphorylation is controlled by phospho-Akt, and higher activity of the mTOR pathway has been demonstrated in both animal models of epilepsy [<xref ref-type="bibr" rid="B18-ijms-20-04127">18</xref>,<xref ref-type="bibr" rid="B19-ijms-20-04127">19</xref>] and patients [<xref ref-type="bibr" rid="B17-ijms-20-04127">17</xref>]. In keeping with this, higher phospho-Akt levels were also present in the cortex of <italic>FoxG1<sup>+/−</sup></italic> mice. Interestingly, stronger activation of mTOR due to Akt mutation leads to cortical malformations and seizures also by disrupting FOXG1-dependent transcriptional control [<xref ref-type="bibr" rid="B20-ijms-20-04127">20</xref>]. It is tempting to speculate that FoxG1 mutations—as observed in our experimental model—can cause hyperactivation of Akt, further impinging on FoxG1-dependent transcriptional control, thus resulting in a pathological positive feedback. Our analysis, showing that most of the genes belonging to the Akt pathway network are direct FoxG1 targets, supports this hypothesis.</p>
<p>Epilepsy is triggered and sustained by disruptions in the delicate balance between excitatory and inhibitory circuits [<xref ref-type="bibr" rid="B21-ijms-20-04127">21</xref>]. Indeed, we found a higher expression of vGluT2, the glutamate transporter isoform specific of subcortical afferents [<xref ref-type="bibr" rid="B22-ijms-20-04127">22</xref>], along with lower levels of the KCC2 potassium-chloride cotransporter, a key regulator of intracellular chloride homeostasis [<xref ref-type="bibr" rid="B23-ijms-20-04127">23</xref>]. The latter result is consistent with our previous findings in the hippocampus [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>], and with the established shift in chloride reversal potential towards more positive values contributing to circuit hyperexcitability in epilepsy [<xref ref-type="bibr" rid="B24-ijms-20-04127">24</xref>]. On the other hand, the hippocampus of <italic>FoxG1<sup>+/-</sup></italic> mice displays a lower expression of vesicular GABA transporter (vGAT), whereas no significant change in this protein could be detected in the cortex (<italic>FoxG1<sup>+/−</sup></italic> 101.2 ± 14.2%, WT 100.0 ± 3.6%, Student’s <italic>t</italic>-test, <italic>p</italic> = 0.937, <italic>n</italic> = 5 for both groups). Taken together with the cortical increase in vGluT2, these data suggest that distinct changes in excitatory and inhibitory synapses can occur in different brain regions of <italic>FoxG1<sup>+/−</sup></italic> mice. These different molecular alterations underlie the same macroscopic functional outcome, namely higher epileptiform EEG event frequency.</p>
<p>At the postsynaptic level, adult <italic>FoxG1<sup>+/−</sup></italic> mice show lower levels of the A1 subunit of glutamate AMPA receptor (GluA1) and of PSD-95, a multifunctional organizer of excitatory synapse structure [<xref ref-type="bibr" rid="B25-ijms-20-04127">25</xref>]. Accordingly, our patch-clamp measurements show decreased mEPSC amplitude, which can represent the electrophysiological readout of decreased density of AMPA receptors. Further work will be required to understand whether the reduction in mEPSC frequency can be ascribed to a presynaptic effect affecting neurotransmitter release, or to a global reduction in the number of excitatory synapses.</p>
<p>Therefore, at the micro-circuit level excitatory synaptic transmission is downregulated, in opposition to the macrocircuit level, which is characterized by higher circuit excitability and seizure propensity (current work, and [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>]). This can be explained as a homeostatic plasticity manifestation [<xref ref-type="bibr" rid="B26-ijms-20-04127">26</xref>], in which spontaneous synaptic transmission is reduced to compensate for pathologically enhanced excitability of a whole brain structure.</p>
<p>Our results provide evidence of opposite changes in macro- and micro-circuit excitability, accompanied by hyperactivation of Akt and S6, which can provide a functional and molecular substrate that contributes to the complex neurological phenotype of <italic>FoxG1</italic>-associated RTT.</p>
</sec>
<sec id="sec4-ijms-20-04127">
<title>4. Materials and Methods </title>
<sec id="sec4dot1-ijms-20-04127">
<title>4.1. Animals</title>
<p>All mice used in this study were males generated by mating <italic>FoxG1<sup>+/-</sup></italic> mice (a generous gift from Dr. Vania Broccoli, “Vita-Salute” University, Milan, Italy) with wild type animals of the same background (C57BL/6J, purchased from the Jackson Laboratories, Bar Harbor, ME, USA). Animals were housed in a 12 h light/dark cycle with free access to food and water. All animal procedures were approved by the Italian Ministry of Health (Decree n°258-2012/B, 23 October 2012) and were fully compliant with Italian (Ministry of Health guidelines, Legislative Decree n°26/2014) and European Union (Directive n°2010/63/UE) laws on animal research. The experimental design was set by taking into account the ARRIVE guidelines, considering the mean values of the electrophysiological, behavioral and biochemical parameters assessed, as well as their associated variances and measured variations. In addition, the principles of the Basel Declaration, including the “3R” concept, were considered throughout the whole project.</p>
</sec>
<sec id="sec4dot2-ijms-20-04127">
<title>4.2. LFP Recordings</title>
<p>Electrode implants were performed at P55 by adapting the techniques described in [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>,<xref ref-type="bibr" rid="B27-ijms-20-04127">27</xref>]. Mice were anesthetized by i.p. zoletil/xylazine (80/10 mg/kg) and mounted on a stereotaxic apparatus, then the skull was exposed. A burr hole was drilled at stereotaxic coordinates corresponding to the primary motor cortex (anteroposterior −1.38 mm, mediolateral 2.00 mm to bregma) [<xref ref-type="bibr" rid="B28-ijms-20-04127">28</xref>]. With the aid of a micromanipulator, a parallel bipolar steel electrode was positioned epidurally. A grounding screw was placed in the occipital bone. The electrodes and the reference were soldered to an electrical connector and the whole implant was secured with dental acrylic cement (Paladur, Pala, Germany). The animals were allowed to recover from anesthesia for 5 days and monitored for any sign of pain or distress during the following week. At the end of this period (corresponding to P60), the animals were placed in a recording chamber, where, after a one-hour habituation, LFP recording sessions lasted 60 min. Recordings were performed starting at 9:00 in the morning, in our case (light on at 8:00, light off at 20:00) corresponding to the tail of the active circadian phase.</p>
<p>The acquisition system consisted of a swivel rotor connected to an amplifier, plugged to a digitalization USB card (National Instruments, Austin, TX, USA). Signals were bandpass filtered (0.3–100 Hz) and amplified 5000 times. Analysis of number and duration of spiking events was performed by means of a LabView-based custom application, by taking the mean baseline amplitude of each signal and by establishing a threshold equal to 4.5 times its standard deviation. Every crossing of this threshold corresponded to a “spike” and spikes were considered to be clustered when separated by less than 1.5 s. Each spike group lasting more than 4 s was classified as “cluster”, whereas single spikes (i.e., with no surrounding spikes within 1.5 s) and spike groups lasting less than 4 s were considered as isolated spiking events [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>,<xref ref-type="bibr" rid="B21-ijms-20-04127">21</xref>]. To better appreciate the changes in event frequency, each individual value was divided by the corresponding WT group mean value, to obtain a normalized fold-change value.</p>
</sec>
<sec id="sec4dot3-ijms-20-04127">
<title>4.3. Western Blotting</title>
<p>Following the same protocol as [<xref ref-type="bibr" rid="B11-ijms-20-04127">11</xref>], mice were euthanized by cervical dislocation, then the brain was extracted and the hippocampi dissected out, frozen in liquid nitrogen and stored at −80 °C until further processing. RIPA buffer containing the following (in mM): NaCl 150, EDTA 5, PMSF 1, TRIS-HCl pH 7.5 10 and Triton X-100 1%, Na-deoxycholate 1%, SDS 0.1%, 1× protease inhibitor cocktail (Sigma-Aldrich, Milan, Italy) was used for protein extraction. After adding the lysis buffer, tissues were sonicated until reaching complete mechanical dissociation, then incubated for 30 min in ice and, finally, centrifuged at 20,000× <italic>g</italic> for 30 min at 4 °C. The supernatant was recovered and the total protein content was measured using a BSA-based Bradford assay (Bio-Rad, Hercules, CA, USA). Protein extracts (30 µg) were run on 10% acrylamide gels for 90 min at 150 V, using a TRIS-glycine buffer containing (in mM): TRIS 25, glycine 192, added with 0.1% SDS. After SDS-PAGE, proteins were transferred on nitrocellulose membranes at 250 mA for 90 min at 4 °C, using TRIS-glycine buffer added with 20% methanol. The blots were blocked for 1 h at RT under gentle rocking using 5% milk and 0.5% Tween in TBS, then incubated O/N at 4 °C under gentle rocking using primary antibody solutions prepared in the same blocking solution. The rabbit polyclonal primary antibodies used were: anti-KCC2 (1:1000, Millipore 07–432, Burlington, MA, USA), anti-phosphoThr<sup>308</sup>-Akt (1:1000, Cell Signaling Tech. 9275), anti-Akt (1:1000, Cell Signaling Tech. 9272), anti-phospho-Ser<sup>235-236</sup>-rpS6 (1:1000, Cell Signaling Tech. 2211), anti-rpS6 (1:1000, Cell Signaling Tech. 2217); GAPDH was revealed using a mouse monoclonal antibody (1:10,000, Fitzgerald Industries Int. 10R-G109a, Acton, MA, USA). Then, blots were rinsed 3 times for 10 min in TBS-Tween, and incubated with either goat anti-rabbit (1:5000, Santa Cruz Biotech. SC-2004, Dallas, TX, USA) or goat anti-mouse (1:10,000, Santa Cruz Biotech. SC-2005) HRP-conjugated secondary antibodies. The signal was revealed with ECL solutions (BioRad) and acquired using a ChemiDoc system (BioRad, Hercules, CA, USA). The optical density was quantified using the ImageJ software (NIH, Bethesda, MD, USA).</p>
</sec>
<sec id="sec4dot4-ijms-20-04127">
<title>4.4. Pathway Analysis</title>
<p>Annotation of FoxG1 target genes was based on the database published in [<xref ref-type="bibr" rid="B6-ijms-20-04127">6</xref>], and performed using the KEGG database, then visualized with Pathview.</p>
</sec>
<sec id="sec4dot5-ijms-20-04127">
<title>4.5. Patch-Clamp Recordings</title>
<p>Acute slices comprising the primary motor cortex were prepared by adapting the protocol described in [<xref ref-type="bibr" rid="B29-ijms-20-04127">29</xref>]. After sacrificing the animal by cervical dislocation, the brain was quickly extracted from the skull and submerged in ice-cold, oxygenated cutting solution containing (in mM): Sucrose 240, NaHCO<sub>3</sub> 15, HEPES 10, glucose 5, KCl 2.5, CaCl<sub>2</sub> 2.4, MgCl<sub>2</sub> 1.2, NaH<sub>2</sub>PO<sub>4</sub> 1.2, pH adjusted to 7.4. 300 μm thick brain sections were cut using a vibratome (Leica VT1200S, Weitzlar, Germany), then transferred to a recovery chamber filled with oxygenated artificial cerebrospinal fluid (aCSF), containing (in mM): NaCl 119, HEPES 10, glucose 10, NaHCO<sub>3</sub> 6.2, KCl 2.5, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 1.2 NaH<sub>2</sub>PO<sub>4</sub> 1, pH adjusted to 7.4, held at 32 °C for 30 min. After moving the chamber to room temperature and allowing 60 more min, slices were transferred to the recording chamber where recordings were performed under continuous perfusion with aCSF at 32 °C. Tetrodotoxin (0.5 μM) and picrotoxin (50 μM) were added to the bath to block the evoked synaptic activity and inhibitory synapses, respectively, in order to isolate miniature excitatory postsynaptic currents (mEPSCs). Patch-clamp recordings were performed using borosilicate glass micropipettes having a 4–6 MΩ resistance when filled with an internal solution containing (in mM): K-gluconate 145, HEPES 10, phosphocreatine 5, Mg<sup>2+</sup>-ATP 2.5, MgCl<sub>2</sub> 2, Na<sup>+</sup>-GTP 0.25, EGTA 0.1, pH adjusted to 7.35 with KOH. Layer II–III pyramidal neurons were approached under DIC illumination, using a 63× immersion objective. After establishing a gigaseal, the patch was broken by applying negative pressure to achieve a whole-cell configuration. A series resistance lower than 15 MΩ was considered acceptable, and monitored constantly throughout the entire recording. At least 3 min were allowed for complete cytosol dialysis, the mEPSCs were recorded while holding the neuron at −70 mV, using a MultiClamp 700A amplifier and a Digidata 1322A card, controlled via Clampex 8.2 software (Molecular Devices, San Jose, CA, USA). Signal analysis was performed as described in [<xref ref-type="bibr" rid="B30-ijms-20-04127">30</xref>].</p>
</sec>
<sec id="sec4dot6-ijms-20-04127">
<title>4.6. Statistics</title>
<p>Statistical significance was assessed using SigmaStat 12 (SyStat Software, San Jose, CA, USA), using Student’s <italic>t</italic>-test. Data are expressed as mean ± SEM.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Nicola Origlia (IN-CNR, Pisa) for technical support in the preparation of brain sections; Francesca Biondi, for excellent assistance in animal care and husbandry.</p>
</ack>
<app-group>
<app id="app1-ijms-20-04127">
<title>Supplementary Materials</title>
<p>Supplementary materials can be found at <uri xlink:href="https://www.mdpi.com/1422-0067/20/17/4127/s1">https://www.mdpi.com/1422-0067/20/17/4127/s1</uri>.</p>
<supplementary-material content-type="local-data" id="ijms-20-04127-s001">
<media xlink:href="ijms-20-04127-s001.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, M.M., M.C. (Matteo Caleo), M.C. (Mario Costa); investigation, G.T., F.O., L.P., M.M.; formal analysis, G.T., M.M., U.B.; writing—original draft preparation, M.M., U.B., M.C. (Mario Costa); supervision, M.C. (Matteo Caleo), A.C.; funding acquisition, A.C., M.C. (Mario Costa).</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded by AIRC, grant “IG 2016-18925” and by Fondazione Pisa, grant “NanoBioMarker 2016”.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-04127">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gulden</surname>
<given-names>F.O.</given-names>
</name>
<name>
<surname>Sestan</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>From trans to cis: Transcriptional regulatory networks in neocortical development</article-title>
<source/>Trends Genet.
          <year>2015</year>
<volume>31</volume>
<fpage>77</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2014.12.004</pub-id>
<pub-id pub-id-type="pmid">25624274</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-04127">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cappello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bohringer</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Bergami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Conzelmann</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Ghanem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tomassy</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Arlotta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Allegra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A radial glia-specific role of RhoA in double cortex formation</article-title>
<source/>Neuron
          <year>2012</year>
<volume>73</volume>
<fpage>911</fpage>
<lpage>924</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.030</pub-id>
<pub-id pub-id-type="pmid">22405202</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-04127">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stouffer</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Neuronal migration disorders: Focus on the cytoskeleton and epilepsy</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>92</volume>
<issue-part>Pt A</issue-part>
<fpage>18</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.08.003</pub-id>
<pub-id pub-id-type="pmid">26299390</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-04127">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eagleson</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Schlueter McFadyen-Ketchum</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Ahrens</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Does</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Nickols</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Disruption of Foxg1 expression by knock-in of cre recombinase: Effects on the development of the mouse telencephalon</article-title>
<source/>Neuroscience
          <year>2007</year>
<volume>148</volume>
<fpage>385</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.06.012</pub-id>
<pub-id pub-id-type="pmid">17640820</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-04127">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanashima</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Brain factor-1 controls the proliferation and differentiation of neocortical progenitor cells through independent mechanisms</article-title>
<source/>J. Neurosci.
          <year>2002</year>
<volume>22</volume>
<fpage>6526</fpage>
<lpage>6536</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-15-06526.2002</pub-id>
<pub-id pub-id-type="pmid">12151532</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-04127">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cargnin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Katzman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections</article-title>
<source/>Neuron
          <year>2018</year>
<volume>100</volume>
<fpage>1083</fpage>
<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.10.016</pub-id>
<pub-id pub-id-type="pmid">30392794</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-04127">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ariani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rondinella</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Artuso</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mencarelli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Spanhol-Rosseto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pollazzon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buoni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spiga</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ricciardi</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FOXG1 is responsible for the congenital variant of Rett syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>2008</year>
<volume>83</volume>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2008.05.015</pub-id>
<pub-id pub-id-type="pmid">18571142</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-04127">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrhart</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sangani</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Curfs</surname>
<given-names>L.M.G.</given-names>
</name>
</person-group>
<article-title>Current developments in the genetics of Rett and Rett-like syndrome</article-title>
<source/>Curr. Opin. Psychiatry
          <year>2018</year>
<volume>31</volume>
<fpage>103</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1097/YCO.0000000000000389</pub-id>
<pub-id pub-id-type="pmid">29206688</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-04127">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mencarelli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Spanhol-Rosseto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Artuso</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rondinella</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Filippis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nectoux</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rubinsztajn</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Moncla</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel FOXG1 mutations associated with the congenital variant of Rett syndrome</article-title>
<source/>J. Med. Genet.
          <year>2010</year>
<volume>47</volume>
<fpage>49</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2009.067884</pub-id>
<pub-id pub-id-type="pmid">19578037</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-04127">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>FoxG1 haploinsufficiency results in impaired neurogenesis in the postnatal hippocampus and contextual memory deficits</article-title>
<source/>Hippocampus
          <year>2006</year>
<volume>16</volume>
<fpage>875</fpage>
<lpage>890</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.20218</pub-id>
<pub-id pub-id-type="pmid">16941454</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-04127">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Testa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olimpico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pancrazi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cattaneo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A triheptanoin-supplemented diet rescues hippocampal hyperexcitability and seizure susceptibility in FoxG1(+/−) mice</article-title>
<source/>Neuropharmacology
          <year>2019</year>
<volume>148</volume>
<fpage>305</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2019.01.005</pub-id>
<pub-id pub-id-type="pmid">30639390</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-04127">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boggio</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Pancrazi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gennaro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lo Rizzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ariani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Panighini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Biagioni</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Visual impairment in FOXG1-mutated individuals and mice</article-title>
<source/>Neuroscience
          <year>2016</year>
<volume>324</volume>
<fpage>496</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.03.027</pub-id>
<pub-id pub-id-type="pmid">27001178</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-04127">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borrie</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Brems</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Legius</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bagni</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways</article-title>
<source/>Annu. Rev. Genom. Hum. Genet.
          <year>2017</year>
<volume>18</volume>
<fpage>115</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-genom-091416-035332</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-04127">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pancrazi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Di Benedetto</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Colombaioni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Della Sala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Testa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Olimpico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zeviani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pozzan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Foxg1 localizes to mitochondria and coordinates cell differentiation and bioenergetics</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>13910</fpage>
<lpage>13915</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1515190112</pub-id>
<pub-id pub-id-type="pmid">26508630</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-04127">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henshall</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Kobow</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Epigenetics and Epilepsy</article-title>
<source/>Cold Spring Harb. Perspect. Med.
          <year>2015</year>
<volume>5</volume>
<fpage>2</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a022731</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-04127">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat</article-title>
<source/>Epilepsia
          <year>2012</year>
<volume>53</volume>
<fpage>506</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03384.x</pub-id>
<pub-id pub-id-type="pmid">22242835</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-04127">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talos</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Gourmaud</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coto</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Martinez-Lage</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy</article-title>
<source/>Ann. Neurol.
          <year>2018</year>
<volume>83</volume>
<fpage>311</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1002/ana.25149</pub-id>
<pub-id pub-id-type="pmid">29331082</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-04127">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawicka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pyronneau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>E6290</fpage>
<lpage>E6297</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1610812113</pub-id>
<pub-id pub-id-type="pmid">27663742</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-04127">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokuda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mahaffey</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Monks</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Faulkner</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Danzer</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Frankel</surname>
<given-names>W.N.</given-names>
</name>
</person-group>
<article-title>A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice</article-title>
<source/>Hum. Mol. Genet.
          <year>2011</year>
<volume>20</volume>
<fpage>988</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq544</pub-id>
<pub-id pub-id-type="pmid">21159799</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-04127">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Guemez-Gamboa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schaffer</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mathern</surname>
<given-names>G.W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development</article-title>
<source/>Nat. Med.
          <year>2015</year>
<volume>21</volume>
<fpage>1445</fpage>
<lpage>1454</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3982</pub-id>
<pub-id pub-id-type="pmid">26523971</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-04127">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pietrasanta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vannini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rossetto</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Tetanus neurotoxin-induced epilepsy in mouse visual cortex</article-title>
<source/>Epilepsia
          <year>2012</year>
<volume>53</volume>
<fpage>e132</fpage>
<lpage>e136</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03510.x</pub-id>
<pub-id pub-id-type="pmid">22577757</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-04127">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Landi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gianfranceschi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Baldini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Pasquale</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Berardi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Environmental enrichment potentiates thalamocortical transmission and plasticity in the adult rat visual cortex</article-title>
<source/>J. Neurosci. Res.
          <year>2010</year>
<volume>88</volume>
<fpage>3048</fpage>
<lpage>3059</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22461</pub-id>
<pub-id pub-id-type="pmid">20722076</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-04127">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahle</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Deeb</surname>
<given-names>T.Z.</given-names>
</name>
<name>
<surname>Puskarjov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silayeva</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kaila</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2</article-title>
<source/>Trends Neurosci.
          <year>2013</year>
<volume>36</volume>
<fpage>726</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.08.006</pub-id>
<pub-id pub-id-type="pmid">24139641</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-04127">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Ari</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Khalilov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kahle</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Cherubini</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The GABA excitatory/inhibitory shift in brain maturation and neurological disorders</article-title>
<source/>Neuroscientist
          <year>2012</year>
<volume>18</volume>
<fpage>467</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1177/1073858412438697</pub-id>
<pub-id pub-id-type="pmid">22547529</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-04127">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patriarchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Amabile</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frullanti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Landucci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lo Rizzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ariani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olimpico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Johanne</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Francesco</surname>
<given-names>M.V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Imbalance of excitatory/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1(+/−) patients and in foxg1(+/−) mice</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2016</year>
<volume>24</volume>
<fpage>871</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2015.216</pub-id>
<pub-id pub-id-type="pmid">26443267</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-04127">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatavarty</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Turrigiano</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>How to scale down postsynaptic strength</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>13179</fpage>
<lpage>13189</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1676-13.2013</pub-id>
<pub-id pub-id-type="pmid">23926271</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-04127">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Garbo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caleo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berardi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sale</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Environmental enrichment strengthens corticocortical interactions and reduces amyloid-beta oligomers in aged mice</article-title>
<source/>Front. Aging Neurosci.
          <year>2014</year>
<volume>6</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2014.00001</pub-id>
<pub-id pub-id-type="pmid">24478697</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-04127">
<label>28.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Paxinos</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>K.J.B.</given-names>
</name>
</person-group>
<source/>The Mouse Brain in Stereotaxic Coordinates
          <edition>2nd ed.</edition>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>San Diego, CA, USA</publisher-loc>
<year>2001</year>
</element-citation>
</ref>
<ref id="B29-ijms-20-04127">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barone</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Melani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scabia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Scali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dattilo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ceccarini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vitti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling</article-title>
<source/>Mol. Neurobiol.
          <year>2018</year>
<volume>55</volume>
<fpage>9267</fpage>
<lpage>9279</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-018-1052-6</pub-id>
<pub-id pub-id-type="pmid">29663284</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-04127">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Spinelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scala</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mattera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fusco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D’Ascenzo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Loss of Leptin-Induced Modulation of Hippocampal Synaptic Trasmission and Signal Transduction in High-Fat Diet-Fed Mice</article-title>
<source/>Front. Cell. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>225</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00225</pub-id>
<pub-id pub-id-type="pmid">28804449</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-04127-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Local Field Potential (LFP) recordings of epileptiform activity in the primary motor cortex of <italic>FoxG1<sup>+/−</sup></italic> mice. (<bold>A</bold>) Representative traces of LFP recordings in wild type controls (WT) and <italic>FoxG1<sup>+/−</sup></italic> mice; (<bold>B</bold>) increase in the total number of high-amplitude spikes in <italic>FoxG1<sup>+/−</sup></italic> mice (WT, <italic>n</italic> = 7; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 7; Student’s <italic>t</italic>-test, *** <italic>p</italic> &lt; 0.001); (<bold>C</bold>) increased high-amplitude spikes in <italic>FoxG1<sup>+/−</sup></italic> mice (WT, <italic>n</italic> = 7; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 7; Student’s <italic>t</italic>-test, *** <italic>p</italic> &lt; 0.001); (<bold>D</bold>) increased interictal events in <italic>FoxG1<sup>+/−</sup></italic> mice (WT, <italic>n</italic> = 7; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 7; Student’s <italic>t</italic>-test, *** <italic>p</italic> &lt; 0.001); (<bold>E</bold>) increased number of electrographic seizures in <italic>FoxG1<sup>+/−</sup></italic> mice (WT, <italic>n</italic> = 7; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 7; Student’s <italic>t</italic>-test, *** <italic>p</italic> &lt; 0.001).</p>
</caption>
<graphic xlink:href="ijms-20-04127-g001"></graphic>
</fig>
<fig id="ijms-20-04127-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Hyperactivation of the Akt/S6 pathway and dysregulation in the excitatory/inhibitory balance in the cortex of <italic>FoxG1<sup>+/−</sup></italic> mice. (<bold>A</bold>) Representative blots and quantifications showing higher Akt phosphorylation in <italic>FoxG1<sup>+/−</sup></italic> mice compared to wild type controls (WT) (WT, <italic>n</italic> = 5; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 5; Student’s <italic>t</italic>-test, * <italic>p</italic> ≤ 0.05); (<bold>B</bold>) representative blots and quantification showing higher S6 phosphorylation in <italic>FoxG1<sup>+/−</sup></italic> mice compared to wild type controls (WT) (WT, <italic>n</italic> = 5; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 5; Student’s <italic>t</italic>-test, * <italic>p</italic> ≤ 0.05); (<bold>C</bold>) representative blots and quantification showing higher vGluT2 expression in <italic>FoxG1<sup>+/−</sup></italic> mice compared to wild type controls (WT) (WT, <italic>n</italic> = 5; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 5; Student’s <italic>t</italic>-test, * <italic>p</italic> ≤ 0.05); (<bold>D</bold>) representative blots and quantification showing lower KCC2 expression in <italic>FoxG1<sup>+/−</sup></italic> mice compared to wild type controls (WT) (WT, <italic>n</italic> = 5; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 5; Student’s <italic>t</italic>-test, * <italic>p</italic> ≤ 0.05).</p>
</caption>
<graphic xlink:href="ijms-20-04127-g002"></graphic>
</fig>
<fig id="ijms-20-04127-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>FoxG1 target genes mapped on the Akt pathway network. Known FoxG1 target genes are highlighted in yellow according to [<xref ref-type="bibr" rid="B6-ijms-20-04127">6</xref>], and comprise Akt and S6, thus validating western blot data shown in <xref ref-type="fig" rid="ijms-20-04127-f002">Figure 2</xref>.</p>
</caption>
<graphic xlink:href="ijms-20-04127-g003"></graphic>
</fig>
<fig id="ijms-20-04127-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Downregulated spontaneous excitatory neurotransmission in the cortex of <italic>FoxG1<sup>+/−</sup></italic> mice. (<bold>A</bold>) Representative traces from mEPSC recordings from wild type (WT) and <italic>FoxG1<sup>+/−</sup></italic> mice; (<bold>B</bold>) cumulative distributions of interevent intervals showing lower mEPSC frequency in <italic>FoxG1<sup>+/−</sup></italic> mice compared to WT controls (WT, <italic>n</italic> = 9; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 9; Kolmogorov–Smirnov test, <italic>p</italic> &lt; 0.001); (<bold>C</bold>) cumulative distributions of event amplitudes showing reduced mEPSC frequency in <italic>FoxG1<sup>+/−</sup></italic> mice compared to WT controls (WT, <italic>n</italic> = 9; <italic>FoxG1<sup>+/−</sup></italic>, <italic>n</italic> = 9; Kolmogorov–Smirnov test, <italic>p</italic> &lt; 0.001).</p>
</caption>
<graphic xlink:href="ijms-20-04127-g004"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>